After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$10.64K

Murphy Andrew J Co-chief Scientific Officer

Transaction date Oct 14, 2026
Public filing date Oct 15, 2026
Filing lag Filed 1 day later

REGN daily price context

Close on/before transaction
$778.36 Oct 14, 2026
First close after public filing
$790.74 Oct 16, 2026
Return after filing · so far
+21.33% Through Nov 11, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
14 shares @ $759.96
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001796226-26-000002
Filing cohort

Transactions in this filing

Showing 15 of 30
Trades
30
Issuers
1
Estimated value
$19.4M
Buys / sales
0 / 27
Transactions reported in the same official filing
Issuer Transaction Traded Value
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $361.43K
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $51.24K
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $353.5K
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $296.24K
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $4.52K
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $26.46K
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $12.12K
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $18.2K
Regeneron Pharmaceuticals, Inc. REGN Current Sale Oct 14, 2026 $10.64K
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $56.29K
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $20.56K
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $41.94K
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $167.4K
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $207.42K
Regeneron Pharmaceuticals, Inc. REGN Sale Oct 14, 2026 $213.85K